Similarly, multiple in vitro studies have demonstrated that BAFF stimulation reduces the chemosensitivity of cancer cells, including multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma cells [26,27,28,29]. The gene discussed is TNFSF13B; the disease is plasma cell myeloma.